Dentsply's $39 Million Inventory Accounting Gain Lifted The Quarter, And The CFO Says It Won't Recur
A one-time estimate change added about $39 million to pre-tax income, and it sits inside guidance the company just cut.
Dentsply Sirona, the dental equipment and consumables maker, booked a change in accounting estimate that added about $39 million to third-quarter gross profit and pre-tax income, CFO John Fortson said on the company's earnings call Thursday. He does not expect a similar benefit in future periods.
A multi-year benefit booked in one quarter
Fortson, Executive Vice President and CFO, said more detailed data ahead of a new financial consolidation system let the company refine its estimate of profit embedded in inventory moved between its businesses. He said the benefit "reflects a multi-year period rather than third quarter operating performance."
After tax the gain is roughly $30 million, Fortson said, and it is included in guidance. That guidance now calls for full-year net sales of about $3.5 billion, against a prior range of $3.5 billion to $3.6 billion, and adjusted earnings per share of $1.20 to $1.30, down from $1.40 to $1.50. Both exclude a 17 cent one-time tariff-refund gain.
Third-quarter revenue was $836 million, down 7.6% as reported and 7% in constant currency. Adjusted earnings per share were 29 cents, down 13 cents from a year earlier. Adjusted gross margin improved 190 basis points, but adjusted gross profit fell about $20 million.
Why a one-time gain stays in guidance
An analyst asked why a multi-year benefit remains in the guidance. Fortson said the company is improving how it analyzes and forecasts, with new consolidation systems and a closer look at financial planning, so adjustments will come through. "You can make your own judgment" on operating EPS, he said.
CEO Dan Scavilla said the item is "not a standalone event," because other cleanup items offset it. Netted out operationally, he said, the figure is "one or two cents."
Fortson said roughly three-fourths of the cut to EPS guidance came from weakness in Europe, the Middle East and Africa and the Middle East conflict. An unfavorable tax rate and strategic investments made up the rest, with the inventory benefit and cost actions offsetting part of it.
Growth pockets and the 2027 question
Dentsply Sirona makes dental equipment, implants, clear aligners and consumables, plus continence care products. Scavilla said its Wellspect continence unit posted record sales, up 10% to $92 million as reported, and he pointed to early gains in U.S. dental, including double-digit U.S. growth in its MIS value implants.
Operating cash flow fell to $32 million from $79 million a year earlier, which Fortson tied to unfavorable working capital. Cash was $195 million and net debt to EBITDA was 3.4.
Asked about 2027, Scavilla said he needs the next one or two months to finish the next phase of the return-to-growth plan and align with the board before saying how the outlook will be presented to the market.
Fortson said reaching the fourth-quarter figures implied by the range is "fairly doable," citing a seasonally stronger equipment quarter and product mix.
Sources
- Dentsply Sirona Non-GAAP EPS of $0.29 misses by $0.02, revenue of $836M misses by $25.65M (XRAY:NASDAQ) | Seeking Alpha — seekingalpha.com
- Market Challenges and Margin Pressure Weigh on Dentsply's Near-Term Results | Morningstar — morningstar.com
- Dentsply (XRAY) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates — Yahoo Finance
- Dentsply Earnings: FVE Lowered as Ongoing Challenges Lower Guidance and Recovery Timing Uncertain | Morningstar — morningstar.com
- Dentsply Sirona Q3 2026 Earnings Call Transcript — benzinga.com